arrow
V

Verena Moos

freie universitaet berlin and humboldt universitaet zu berlin
H指数:33
被引数:4,495

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim–sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trial

德国对惠普尔病进行多西环素和羟氯喹口服治疗与头孢曲松静脉给药后接甲氧苄啶-磺胺甲噁唑口服治疗的比较:一项2/3期、前瞻性、开放标签、随机对照、非劣效性试验

2025-02-170
OAAI
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
CELLS
IF5.2
2021-12-1315
OAAI
Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells
2021-11-0155
OAAI
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
2019-04-1950
PREAI